Michael Wilson
Concepts (270)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emergency Service, Hospital | 56 | 2023 | 538 | 10.100 |
Why?
| Psychomotor Agitation | 18 | 2022 | 53 | 6.290 |
Why?
| Mental Disorders | 18 | 2023 | 451 | 6.180 |
Why?
| Antipsychotic Agents | 16 | 2022 | 247 | 5.100 |
Why?
| Emergency Medicine | 9 | 2022 | 60 | 2.980 |
Why?
| Benzodiazepines | 12 | 2017 | 72 | 2.880 |
Why?
| Mass Screening | 9 | 2023 | 370 | 2.680 |
Why?
| Emergency Services, Psychiatric | 6 | 2020 | 15 | 2.240 |
Why?
| Haloperidol | 6 | 2022 | 41 | 2.180 |
Why?
| Alcoholic Intoxication | 7 | 2017 | 24 | 1.990 |
Why?
| Risk Assessment | 9 | 2020 | 1361 | 1.960 |
Why?
| Emergencies | 5 | 2022 | 92 | 1.470 |
Why?
| Risperidone | 3 | 2017 | 25 | 1.370 |
Why?
| Mental Health | 2 | 2023 | 244 | 1.330 |
Why?
| Humans | 75 | 2023 | 54246 | 1.250 |
Why?
| Suicidal Ideation | 4 | 2022 | 96 | 1.220 |
Why?
| Opioid-Related Disorders | 3 | 2021 | 367 | 1.170 |
Why?
| Psychotic Disorders | 2 | 2019 | 144 | 1.150 |
Why?
| Vital Signs | 2 | 2017 | 18 | 1.090 |
Why?
| Adult | 30 | 2021 | 14182 | 1.050 |
Why?
| Consensus | 5 | 2021 | 157 | 1.020 |
Why?
| Delirium | 4 | 2019 | 52 | 0.910 |
Why?
| Practice Guidelines as Topic | 5 | 2021 | 492 | 0.860 |
Why?
| Male | 35 | 2021 | 27312 | 0.810 |
Why?
| Thiazoles | 3 | 2022 | 61 | 0.790 |
Why?
| Substance-Related Disorders | 5 | 2020 | 671 | 0.790 |
Why?
| Thyroid Crisis | 2 | 2017 | 6 | 0.770 |
Why?
| Hepatitis C, Chronic | 2 | 2013 | 89 | 0.770 |
Why?
| Piperazines | 3 | 2022 | 116 | 0.750 |
Why?
| Female | 32 | 2021 | 28418 | 0.740 |
Why?
| Guideline Adherence | 1 | 2021 | 147 | 0.730 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 596 | 0.720 |
Why?
| Nurses | 1 | 2020 | 52 | 0.700 |
Why?
| Middle Aged | 21 | 2019 | 13070 | 0.690 |
Why?
| Prescription Drug Misuse | 1 | 2019 | 30 | 0.680 |
Why?
| Droperidol | 2 | 2015 | 7 | 0.680 |
Why?
| Drug Monitoring | 1 | 2019 | 85 | 0.680 |
Why?
| Preventive Health Services | 1 | 2019 | 53 | 0.670 |
Why?
| Drug Therapy, Combination | 7 | 2017 | 426 | 0.670 |
Why?
| Geriatrics | 1 | 2019 | 47 | 0.660 |
Why?
| Informed Consent | 1 | 2019 | 92 | 0.650 |
Why?
| Schizophrenia | 2 | 2019 | 276 | 0.640 |
Why?
| Retrospective Studies | 15 | 2022 | 6432 | 0.640 |
Why?
| Diagnosis, Differential | 9 | 2019 | 1136 | 0.630 |
Why?
| Pain Management | 1 | 2019 | 155 | 0.630 |
Why?
| Anesthetics, Dissociative | 2 | 2015 | 16 | 0.630 |
Why?
| Aggression | 2 | 2015 | 60 | 0.620 |
Why?
| Analgesics, Opioid | 2 | 2019 | 501 | 0.610 |
Why?
| Pheochromocytoma | 1 | 2017 | 38 | 0.600 |
Why?
| Substance Abuse Detection | 1 | 2017 | 92 | 0.600 |
Why?
| Psychological Tests | 1 | 2017 | 54 | 0.600 |
Why?
| Medical History Taking | 1 | 2017 | 51 | 0.600 |
Why?
| Physicians | 2 | 2020 | 247 | 0.600 |
Why?
| Patient Selection | 1 | 2019 | 286 | 0.590 |
Why?
| Oxygen | 4 | 2013 | 361 | 0.590 |
Why?
| Hypotension | 1 | 2017 | 67 | 0.580 |
Why?
| Physical Examination | 1 | 2017 | 99 | 0.580 |
Why?
| Neuroleptic Malignant Syndrome | 1 | 2016 | 3 | 0.580 |
Why?
| Psychiatric Status Rating Scales | 1 | 2018 | 346 | 0.580 |
Why?
| Age Factors | 2 | 2017 | 1195 | 0.570 |
Why?
| Patient Acceptance of Health Care | 1 | 2020 | 331 | 0.570 |
Why?
| Steroids | 1 | 2016 | 53 | 0.570 |
Why?
| Attitude of Health Personnel | 1 | 2020 | 397 | 0.570 |
Why?
| Databases, Factual | 1 | 2019 | 684 | 0.560 |
Why?
| Administration, Oral | 5 | 2017 | 459 | 0.550 |
Why?
| Serotonin Syndrome | 1 | 2015 | 7 | 0.550 |
Why?
| Ketamine | 2 | 2017 | 61 | 0.540 |
Why?
| Injections, Intramuscular | 5 | 2020 | 50 | 0.530 |
Why?
| Disease Management | 2 | 2016 | 184 | 0.520 |
Why?
| Cocaine-Related Disorders | 1 | 2017 | 246 | 0.500 |
Why?
| Length of Stay | 2 | 2015 | 683 | 0.490 |
Why?
| Pain, Referred | 1 | 2014 | 1 | 0.490 |
Why?
| Toothache | 1 | 2014 | 2 | 0.490 |
Why?
| Alcoholism | 2 | 2016 | 249 | 0.490 |
Why?
| Facial Pain | 1 | 2014 | 14 | 0.490 |
Why?
| Depressive Disorder | 3 | 2013 | 368 | 0.480 |
Why?
| Hepatitis B, Chronic | 1 | 2013 | 15 | 0.460 |
Why?
| Fasciitis, Necrotizing | 1 | 2012 | 6 | 0.450 |
Why?
| Substance Withdrawal Syndrome | 3 | 2021 | 179 | 0.450 |
Why?
| Suicide | 3 | 2019 | 77 | 0.450 |
Why?
| Acute Disease | 5 | 2017 | 403 | 0.450 |
Why?
| Confined Spaces | 1 | 2012 | 4 | 0.420 |
Why?
| Firefighters | 1 | 2012 | 7 | 0.420 |
Why?
| United States | 9 | 2023 | 5200 | 0.400 |
Why?
| Safety | 1 | 2012 | 92 | 0.400 |
Why?
| Blood Pressure | 4 | 2017 | 586 | 0.400 |
Why?
| Pregnancy Complications | 1 | 2015 | 384 | 0.390 |
Why?
| Pilot Projects | 4 | 2022 | 808 | 0.390 |
Why?
| Social Adjustment | 1 | 2010 | 31 | 0.360 |
Why?
| Prospective Studies | 5 | 2019 | 2604 | 0.360 |
Why?
| Myocardial Infarction | 1 | 2014 | 424 | 0.360 |
Why?
| Aged | 9 | 2019 | 10041 | 0.350 |
Why?
| Heart Rate | 3 | 2017 | 357 | 0.340 |
Why?
| HIV Infections | 1 | 2013 | 394 | 0.340 |
Why?
| Geriatric Assessment | 2 | 2019 | 126 | 0.330 |
Why?
| Delivery of Health Care | 5 | 2023 | 327 | 0.320 |
Why?
| Anxiety | 3 | 2020 | 278 | 0.320 |
Why?
| Social Support | 1 | 2010 | 298 | 0.310 |
Why?
| Liver Cirrhosis | 1 | 2010 | 216 | 0.310 |
Why?
| Pandemics | 3 | 2021 | 579 | 0.300 |
Why?
| Sweating | 2 | 2017 | 19 | 0.300 |
Why?
| Advisory Committees | 2 | 2017 | 66 | 0.290 |
Why?
| Publishing | 1 | 2007 | 45 | 0.290 |
Why?
| Drug Interactions | 3 | 2012 | 206 | 0.290 |
Why?
| Periodicals as Topic | 1 | 2007 | 65 | 0.280 |
Why?
| Emergency Medical Services | 2 | 2022 | 126 | 0.280 |
Why?
| Young Adult | 7 | 2021 | 4308 | 0.280 |
Why?
| Patient Discharge | 3 | 2023 | 353 | 0.270 |
Why?
| Predictive Value of Tests | 2 | 2019 | 1048 | 0.260 |
Why?
| Restraint, Physical | 2 | 2022 | 21 | 0.260 |
Why?
| California | 3 | 2019 | 90 | 0.250 |
Why?
| Oxytocin | 2 | 2013 | 18 | 0.240 |
Why?
| Feasibility Studies | 2 | 2022 | 398 | 0.230 |
Why?
| Fever | 2 | 2016 | 129 | 0.230 |
Why?
| Risk Factors | 6 | 2017 | 3930 | 0.220 |
Why?
| Psychotherapy | 2 | 2013 | 106 | 0.220 |
Why?
| Aftercare | 2 | 2023 | 81 | 0.210 |
Why?
| Antidepressive Agents | 2 | 2013 | 187 | 0.210 |
Why?
| Dextroamphetamine | 1 | 2021 | 36 | 0.210 |
Why?
| Referral and Consultation | 2 | 2021 | 307 | 0.200 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2017 | 24 | 0.200 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2020 | 21 | 0.190 |
Why?
| Akathisia, Drug-Induced | 1 | 2020 | 13 | 0.190 |
Why?
| Narcotic Antagonists | 1 | 2021 | 127 | 0.190 |
Why?
| Emergency Nursing | 1 | 2020 | 9 | 0.190 |
Why?
| Crisis Intervention | 1 | 2020 | 10 | 0.190 |
Why?
| Amphetamine-Related Disorders | 1 | 2021 | 125 | 0.190 |
Why?
| Myocardial Ischemia | 1 | 2021 | 127 | 0.190 |
Why?
| Death, Sudden | 1 | 2019 | 13 | 0.180 |
Why?
| Meningoencephalitis | 1 | 2019 | 8 | 0.170 |
Why?
| Buprenorphine | 1 | 2021 | 132 | 0.170 |
Why?
| Meningitis, Cryptococcal | 1 | 2019 | 12 | 0.170 |
Why?
| Loxapine | 1 | 2019 | 2 | 0.170 |
Why?
| Lorazepam | 1 | 2019 | 13 | 0.170 |
Why?
| Analysis of Variance | 2 | 2011 | 635 | 0.170 |
Why?
| Methamphetamine | 1 | 2021 | 233 | 0.170 |
Why?
| Ethanol | 2 | 2013 | 322 | 0.170 |
Why?
| Ethics, Research | 1 | 2019 | 41 | 0.170 |
Why?
| Central Nervous System Stimulants | 1 | 2021 | 255 | 0.170 |
Why?
| Hypercalcemia | 1 | 2018 | 36 | 0.160 |
Why?
| Qualitative Research | 1 | 2020 | 331 | 0.160 |
Why?
| Ambulatory Care Facilities | 1 | 2019 | 136 | 0.160 |
Why?
| Child | 5 | 2019 | 7337 | 0.160 |
Why?
| Hypnotics and Sedatives | 3 | 2017 | 74 | 0.160 |
Why?
| Hospitals, University | 2 | 2018 | 89 | 0.160 |
Why?
| Prisoners | 1 | 2019 | 84 | 0.160 |
Why?
| Health Services Research | 1 | 2019 | 166 | 0.160 |
Why?
| Stress, Physiological | 1 | 2019 | 194 | 0.160 |
Why?
| Respiratory Rate | 1 | 2017 | 8 | 0.160 |
Why?
| Psychiatry | 1 | 2019 | 116 | 0.150 |
Why?
| Comorbidity | 2 | 2017 | 663 | 0.150 |
Why?
| Goals | 1 | 2017 | 50 | 0.150 |
Why?
| Headache | 1 | 2017 | 78 | 0.150 |
Why?
| Adrenal Gland Neoplasms | 1 | 2017 | 54 | 0.150 |
Why?
| Physician-Patient Relations | 1 | 2018 | 150 | 0.150 |
Why?
| Korsakoff Syndrome | 1 | 2016 | 1 | 0.150 |
Why?
| Bipolar Disorder | 1 | 2019 | 211 | 0.150 |
Why?
| Chronic Pain | 1 | 2019 | 147 | 0.150 |
Why?
| Pneumonia, Viral | 1 | 2020 | 184 | 0.140 |
Why?
| Muscle Rigidity | 1 | 2016 | 1 | 0.140 |
Why?
| Thiamine | 1 | 2016 | 18 | 0.140 |
Why?
| Vitamin B Complex | 1 | 2016 | 21 | 0.140 |
Why?
| Patient Satisfaction | 1 | 2018 | 304 | 0.140 |
Why?
| Coronavirus Infections | 1 | 2020 | 192 | 0.140 |
Why?
| Catatonia | 1 | 2016 | 11 | 0.140 |
Why?
| Regression Analysis | 1 | 2017 | 445 | 0.140 |
Why?
| Communication | 1 | 2018 | 273 | 0.140 |
Why?
| Veterans | 1 | 2023 | 629 | 0.140 |
Why?
| Polypharmacy | 1 | 2015 | 15 | 0.140 |
Why?
| Suicide, Attempted | 2 | 2022 | 73 | 0.140 |
Why?
| Health Policy | 1 | 2017 | 171 | 0.140 |
Why?
| Retreatment | 1 | 2015 | 57 | 0.130 |
Why?
| Anti-Inflammatory Agents | 1 | 2016 | 175 | 0.130 |
Why?
| Dibenzothiazepines | 1 | 2014 | 9 | 0.120 |
Why?
| Chronic Disease | 1 | 2017 | 612 | 0.120 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 132 | 0.120 |
Why?
| Jaw | 1 | 2014 | 4 | 0.120 |
Why?
| Quinolones | 1 | 2014 | 35 | 0.120 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2013 | 46 | 0.120 |
Why?
| Adolescent | 4 | 2019 | 6885 | 0.120 |
Why?
| Drug Prescriptions | 1 | 2014 | 89 | 0.120 |
Why?
| Drug Overdose | 1 | 2015 | 154 | 0.110 |
Why?
| Hand Disinfection | 1 | 2013 | 10 | 0.110 |
Why?
| Aged, 80 and over | 2 | 2019 | 3429 | 0.110 |
Why?
| Breath Tests | 1 | 2013 | 44 | 0.110 |
Why?
| Leukocyte Count | 1 | 2012 | 77 | 0.110 |
Why?
| Cohort Studies | 1 | 2017 | 1543 | 0.110 |
Why?
| Sodium | 1 | 2012 | 102 | 0.110 |
Why?
| Creatinine | 1 | 2012 | 169 | 0.110 |
Why?
| Lactic Acid | 1 | 2012 | 90 | 0.110 |
Why?
| Hemoglobins | 1 | 2012 | 126 | 0.110 |
Why?
| Forensic Psychiatry | 1 | 2012 | 7 | 0.110 |
Why?
| United States Occupational Safety and Health Administration | 1 | 2012 | 5 | 0.110 |
Why?
| Sodium Bicarbonate | 1 | 2012 | 9 | 0.110 |
Why?
| Sex Factors | 1 | 2015 | 765 | 0.110 |
Why?
| Hazardous Substances | 1 | 2012 | 16 | 0.100 |
Why?
| Acidosis | 1 | 2012 | 38 | 0.100 |
Why?
| C-Reactive Protein | 1 | 2012 | 159 | 0.100 |
Why?
| Fluid Therapy | 1 | 2012 | 87 | 0.100 |
Why?
| Hypothermia, Induced | 1 | 2012 | 47 | 0.100 |
Why?
| Occupational Health | 1 | 2012 | 74 | 0.100 |
Why?
| Anti-Dyskinesia Agents | 1 | 2010 | 1 | 0.100 |
Why?
| Sick Role | 1 | 2010 | 14 | 0.090 |
Why?
| Liver Function Tests | 1 | 2010 | 43 | 0.090 |
Why?
| Personality Inventory | 1 | 2010 | 50 | 0.090 |
Why?
| Interferons | 1 | 2010 | 44 | 0.090 |
Why?
| Behavior Therapy | 1 | 2012 | 203 | 0.090 |
Why?
| Religion and Psychology | 1 | 2010 | 27 | 0.090 |
Why?
| Alcohol-Related Disorders | 1 | 2010 | 55 | 0.090 |
Why?
| Blood Glucose | 1 | 2012 | 488 | 0.090 |
Why?
| Viral Load | 1 | 2010 | 85 | 0.090 |
Why?
| Social Environment | 1 | 2010 | 95 | 0.090 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 490 | 0.090 |
Why?
| Psychometrics | 1 | 2010 | 241 | 0.080 |
Why?
| Cross-Sectional Studies | 2 | 2014 | 1679 | 0.080 |
Why?
| Transportation of Patients | 1 | 2008 | 39 | 0.080 |
Why?
| Antiviral Agents | 1 | 2010 | 188 | 0.080 |
Why?
| Pregnancy | 1 | 2015 | 2620 | 0.080 |
Why?
| Time Factors | 2 | 2012 | 3212 | 0.080 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 49 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 1213 | 0.070 |
Why?
| Research Support as Topic | 1 | 2007 | 51 | 0.070 |
Why?
| Hydrocortisone | 2 | 2019 | 124 | 0.070 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 570 | 0.070 |
Why?
| Double-Blind Method | 2 | 2021 | 742 | 0.070 |
Why?
| Evidence-Based Medicine | 2 | 2017 | 281 | 0.070 |
Why?
| Quality of Life | 1 | 2010 | 922 | 0.060 |
Why?
| Stroke | 1 | 2008 | 524 | 0.060 |
Why?
| United States Department of Veterans Affairs | 1 | 2023 | 315 | 0.050 |
Why?
| Quality of Health Care | 1 | 2023 | 222 | 0.050 |
Why?
| Dynorphins | 1 | 2019 | 4 | 0.040 |
Why?
| Police | 1 | 2019 | 4 | 0.040 |
Why?
| Glycopeptides | 1 | 2019 | 15 | 0.040 |
Why?
| Sampling Studies | 1 | 2019 | 40 | 0.040 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2019 | 83 | 0.040 |
Why?
| Diuretics, Osmotic | 1 | 2019 | 4 | 0.040 |
Why?
| Consciousness Disorders | 1 | 2019 | 7 | 0.040 |
Why?
| Mannitol | 1 | 2019 | 15 | 0.040 |
Why?
| Intracranial Hypertension | 1 | 2019 | 31 | 0.040 |
Why?
| Cryptococcus neoformans | 1 | 2019 | 28 | 0.040 |
Why?
| Education | 1 | 2019 | 47 | 0.040 |
Why?
| Norepinephrine | 1 | 2019 | 119 | 0.040 |
Why?
| Guidelines as Topic | 1 | 2019 | 125 | 0.040 |
Why?
| Text Messaging | 1 | 2018 | 18 | 0.040 |
Why?
| Telephone | 1 | 2018 | 75 | 0.040 |
Why?
| Conscious Sedation | 1 | 2017 | 28 | 0.040 |
Why?
| Dementia | 1 | 2019 | 149 | 0.040 |
Why?
| Emergency Treatment | 1 | 2017 | 32 | 0.040 |
Why?
| Health Personnel | 1 | 2020 | 246 | 0.040 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2017 | 51 | 0.040 |
Why?
| Flumazenil | 1 | 2016 | 6 | 0.040 |
Why?
| Psychoses, Substance-Induced | 1 | 2016 | 8 | 0.040 |
Why?
| Phenobarbital | 1 | 2016 | 17 | 0.040 |
Why?
| Delusions | 1 | 2016 | 7 | 0.040 |
Why?
| Patient Readmission | 1 | 2018 | 242 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 1228 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 50 | 0.030 |
Why?
| Mental Health Services | 1 | 2017 | 242 | 0.030 |
Why?
| Theory of Mind | 1 | 2013 | 2 | 0.030 |
Why?
| Interview, Psychological | 1 | 2013 | 25 | 0.030 |
Why?
| Phobic Disorders | 1 | 2013 | 15 | 0.030 |
Why?
| Behavior | 1 | 2013 | 49 | 0.030 |
Why?
| Saliva | 1 | 2013 | 63 | 0.030 |
Why?
| False Positive Reactions | 1 | 2013 | 68 | 0.030 |
Why?
| Affect | 1 | 2013 | 104 | 0.030 |
Why?
| Social Behavior | 1 | 2013 | 85 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2014 | 746 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2013 | 363 | 0.030 |
Why?
| Cognition | 1 | 2013 | 348 | 0.020 |
Why?
| Child, Preschool | 1 | 2014 | 4146 | 0.020 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|